Search results

5 items
  1. MDMA (‘ecstasy’)

    01 February 2008
    Report

    Due to its prevalence of use, MDMA is a significant public health issue. The Council believes that criminal justice measures will only have limited effect and strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health.

  2. coca

    Abolishing Coca Leaf Consumption?

    Transnational Institute
    05 March 2008
    Press release

    The Transnational Institute condemns the decision by the International Narcotics Control Board (INCB) in their 2007 annual report released today, which calls on countries to ‘abolish or prohibit coca leaf chewing and the manufacture of coca tea’.

  3. Cannabis: Classification and Public Health

    01 April 2008
    Report

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  4. The current state of drug policy debate

    • Martin Jelsma
    30 April 2008

    Martin Jelsma, from the Transnational Institute, prepared an analysis for the Latin American Commission on Drugs and Democracy, explaining the drug policy situation in the European Union and the current state of debate in the United Nations agenda. The commission is an initiative born of former presidents Fernando Henrique Cardoso, from Brazil, César Gaviria, from Colombia and Ernesto Zedillo, from Mexico, to respond to concerns related to the problems of drug consumption and traffic in Latin America. The idea to constitute a commission capable of consolidating a debate concerning this problematic also responds to the necessity of reviewing the world drug policies in the scope of the United Nations, which began in March 2008.

  5. Risk assessment of khat use in the Netherlands

    • E.J.M. Pennings, A. Opperhuizen, J.G.C. van Amsterdam
    22 August 2008
    Paper

    In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects).